NASDAQ:SSKN STRATA Skin Sciences (SSKN) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free SSKN Stock Alerts $0.38 -0.07 (-15.63%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.36▼$0.4450-Day Range$0.38▼$0.5652-Week Range$0.26▼$1.15Volume136,664 shsAverage Volume19,501 shsMarket Capitalization$13.25 millionP/E RatioN/ADividend YieldN/APrice Target$3.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get STRATA Skin Sciences alerts: Email Address STRATA Skin Sciences MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside905.3% Upside$3.80 Price TargetShort InterestHealthy1.19% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.18Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.07) to $0.06 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.70 out of 5 starsMedical Sector715th out of 939 stocksSurgical & Medical Instruments Industry77th out of 97 stocks 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $3.80, STRATA Skin Sciences has a forecasted upside of 905.3% from its current price of $0.38.Amount of Analyst CoverageSTRATA Skin Sciences has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.19% of the float of STRATA Skin Sciences has been sold short.Short Interest Ratio / Days to CoverSTRATA Skin Sciences has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in STRATA Skin Sciences has recently decreased by 2.16%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSTRATA Skin Sciences does not currently pay a dividend.Dividend GrowthSTRATA Skin Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SSKN. Previous Next 2.9 News and Social Media Coverage News SentimentSTRATA Skin Sciences has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for STRATA Skin Sciences this week, compared to 1 article on an average week.Search Interest1 people have searched for SSKN on MarketBeat in the last 30 days. MarketBeat Follows1 people have added STRATA Skin Sciences to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STRATA Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders40.43% of the stock of STRATA Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.43% of the stock of STRATA Skin Sciences is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for STRATA Skin Sciences are expected to grow in the coming year, from ($0.07) to $0.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STRATA Skin Sciences is -1.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of STRATA Skin Sciences is -1.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSTRATA Skin Sciences has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW About STRATA Skin Sciences Stock (NASDAQ:SSKN)STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.Read More SSKN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SSKN Stock News HeadlinesMarch 28, 2024 | benzinga.comEarnings Preview For Strata Skin SciencesMarch 28, 2024 | finance.yahoo.comQ4 2023 STRATA Skin Sciences Inc Earnings CallMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…March 27, 2024 | benzinga.comRecap: Strata Skin Sciences Q4 EarningsMarch 27, 2024 | globenewswire.comSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsMarch 20, 2024 | americanbankingnews.comSTRATA Skin Sciences (SSKN) Scheduled to Post Quarterly Earnings on WednesdayMarch 13, 2024 | globenewswire.comSTRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024March 11, 2024 | msn.comSpearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin TreatmentsMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…March 7, 2024 | globenewswire.comSTRATA Skin Sciences Announces Initiative to Expand Treatment CoverageMarch 3, 2024 | seekingalpha.comSSKN STRATA Skin Sciences, Inc.February 29, 2024 | msn.comSTRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic InitiativesFebruary 27, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialFebruary 26, 2024 | globenewswire.comSTRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialFebruary 22, 2024 | morningstar.comStrata Skin Sciences Inc SSKNJanuary 11, 2024 | finance.yahoo.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?January 8, 2024 | finance.yahoo.comSTRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 ConferenceJanuary 3, 2024 | finance.yahoo.comSTRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid RequirementDecember 29, 2023 | markets.businessinsider.comSTRATA Skin Sciences Expands Direct Distribution Agreement With Kosmo MeditechDecember 29, 2023 | finance.yahoo.comSTRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo MeditechDecember 4, 2023 | finance.yahoo.comSTRATA Skin Science Announces Strengthening of Leadership TeamNovember 18, 2023 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Third Quarter 2023 RevenueNovember 14, 2023 | msn.comSTRATA Skin Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $8.85M beats by $0.13MNovember 14, 2023 | finance.yahoo.comSTRATA Skin Sciences Reports Third Quarter 2023 RevenueNovember 13, 2023 | seekingalpha.comSTRATA Skin Sciences Q3 2023 Earnings PreviewNovember 2, 2023 | finance.yahoo.comSTRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023October 3, 2023 | finance.yahoo.comSTRATA Skin Sciences to Participate in Upcoming Medical ConferencesSee More Headlines Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/31/2023Today3/29/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SSKN CUSIPN/A CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees114Year FoundedN/APrice Target and Rating Average Stock Price Target$3.80 High Stock Price Target$3.80 Low Stock Price Target$3.80 Potential Upside/Downside+905.3%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,550,000.00 Net Margins-20.40% Pretax Margin-20.22% Return on Equity-38.76% Return on Assets-14.12% Debt Debt-to-Equity Ratio0.93 Current Ratio1.64 Quick Ratio1.13 Sales & Book Value Annual Sales$36.16 million Price / Sales0.37 Cash Flow$0.01 per share Price / Cash Flow53.96 Book Value$0.63 per share Price / Book0.60Miscellaneous Outstanding Shares35,050,000Free Float20,879,000Market Cap$13.25 million OptionableNot Optionable Beta1.60 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Christopher Lesovitz (Age 42)Chief Financial Officer Comp: $313.75kMr. Shmuel Gov (Age 64)Chief Operating Officer Comp: $470.52kDr. Dolev Rafaeli Ph.D. (Age 60)President, CEO & Vice-Chairman Comp: $282.72kMr. Jay Sturm (Age 68)General Counsel & Corporate Secretary Mr. Michael E. GoodmanHead of International SalesMr. Michael R. Stewart (Age 67)Independent Consultant Comp: $732.9kMore ExecutivesKey CompetitorsPAVmedNASDAQ:PAVMNEXGELNASDAQ:NXGLPetVivoNASDAQ:PETVMeihua International Medical TechnologiesNASDAQ:MHUAMicrobot MedicalNASDAQ:MBOTView All CompetitorsInsiders & InstitutionsChicago Partners Investment Group LLCBought 39,706 shares on 2/23/2024Ownership: 0.183%Nantahala Capital Management LLCSold 136,813 shares on 2/15/2024Ownership: 8.925%Cannell Capital LLCSold 75,805 shares on 2/15/2024Ownership: 0.787%Shmuel GovBought 20,000 shares on 12/1/2023Total: $9,000.00 ($0.45/share)Samuel RubinsteinSold 1,000 sharesTotal: $320.00 ($0.32/share)View All Insider TransactionsView All Institutional Transactions SSKN Stock Analysis - Frequently Asked Questions What is STRATA Skin Sciences' stock price target for 2024? 0 equities research analysts have issued twelve-month price objectives for STRATA Skin Sciences' stock. Their SSKN share price targets range from $3.80 to $3.80. On average, they anticipate the company's stock price to reach $3.80 in the next year. This suggests a possible upside of 905.3% from the stock's current price. View analysts price targets for SSKN or view top-rated stocks among Wall Street analysts. How have SSKN shares performed in 2024? STRATA Skin Sciences' stock was trading at $0.5501 on January 1st, 2024. Since then, SSKN stock has decreased by 31.3% and is now trading at $0.3780. View the best growth stocks for 2024 here. When is STRATA Skin Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our SSKN earnings forecast. How were STRATA Skin Sciences' earnings last quarter? STRATA Skin Sciences, Inc. (NASDAQ:SSKN) posted its earnings results on Friday, March, 31st. The medical device company reported ($0.05) earnings per share (EPS) for the quarter. The medical device company had revenue of $10.60 million for the quarter. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 48.91% and a negative net margin of 32.47%. During the same period last year, the company posted ($0.02) earnings per share. When did STRATA Skin Sciences' stock split? STRATA Skin Sciences shares reverse split before market open on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of STRATA Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX). Who are STRATA Skin Sciences' major shareholders? STRATA Skin Sciences' stock is owned by many different retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (8.93%), Cannell Capital LLC (0.79%) and Chicago Partners Investment Group LLC (0.18%). Insiders that own company stock include Christopher Lesovitz, Robert Joseph Moccia, Samuel Rubinstein, Shmuel Gov and William D Humphries. View institutional ownership trends. How do I buy shares of STRATA Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SSKN) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STRATA Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.